STEVANATO GROUP S.P.A. Financials Stevanato Group S.p.A.
Equities
STVN
IT0005452658
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.54 USD | +2.12% |
|
+0.95% | -31.75% |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 5,227 | 4,445 | 6,583 | 4,618 | - | - |
| Enterprise Value (EV) 2 | 5,037 | 4,445 | 7,085 | 4,892 | 4,866 | 4,633 |
| P/E ratio | 39 x | 31.4 x | 45.5 x | 33.9 x | 27.2 x | 22.5 x |
| Yield | 0.25% | - | 0.22% | 0.38% | 0.4% | 0.42% |
| Capitalization / Revenue | 6.19 x | 4.52 x | 6.06 x | 4.09 x | 3.69 x | 3.29 x |
| EV / Revenue | 5.97 x | 4.52 x | 6.53 x | 4.33 x | 3.88 x | 3.3 x |
| EV / EBITDA | 23.1 x | 16.9 x | 24.3 x | 17.6 x | 14.6 x | 11.9 x |
| EV / FCF | 197 x | -33.7 x | -21.6 x | -69.4 x | 85.1 x | 35.2 x |
| FCF Yield | 0.51% | -2.96% | -4.63% | -1.44% | 1.18% | 2.84% |
| Price to Book | 6.16 x | - | 5.84 x | 3.2 x | 2.91 x | 2.61 x |
| Nbr of stocks (in thousands) | 264,699 | 264,699 | 266,234 | 272,769 | - | - |
| Reference price 3 | 22.45 | 17.97 | 27.29 | 18.16 | 18.16 | 18.16 |
| Announcement Date | 3/8/22 | 3/2/23 | 3/7/24 | - | - | - |
1USD in Million2EUR in Million3USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 843.9 | 983.7 | 1,085 | 1,129 | 1,253 | 1,405 |
| EBITDA 1 | - | 218.3 | 263.6 | 291.5 | 278 | 333.9 | 390.1 |
| EBIT 1 | - | 161.9 | 198.7 | 213 | 187.4 | 231.2 | 275.5 |
| Operating Margin | - | 19.18% | 20.2% | 19.62% | 16.6% | 18.46% | 19.6% |
| Earnings before Tax (EBT) 1 | - | 165.7 | 187.6 | 189.6 | 176.1 | 223.5 | 272.6 |
| Net income 1 | 78.51 | 134.3 | 143 | 145.7 | 131.7 | 165.2 | 201 |
| Net margin | - | 15.91% | 14.54% | 13.42% | 11.66% | 13.19% | 14.31% |
| EPS 2 | 1.071 | 0.5756 | 0.5726 | 0.5996 | 0.5358 | 0.6685 | 0.8070 |
| Free Cash Flow 1 | - | 25.6 | -131.7 | -328 | -70.5 | 57.2 | 131.6 |
| FCF margin | - | 3.03% | -13.39% | -30.22% | -6.24% | 4.57% | 9.37% |
| FCF Conversion (EBITDA) | - | 11.73% | - | - | - | 17.13% | 33.75% |
| FCF Conversion (Net income) | - | 19.06% | - | - | - | 34.62% | 65.49% |
| Dividend per Share 2 | - | 0.0555 | - | 0.0590 | 0.0688 | 0.0726 | 0.0768 |
| Announcement Date | 4/30/21 | 3/8/22 | 3/2/23 | 3/7/24 | - | - | - |
1EUR in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 232.6 | 212.1 | 234.2 | 245.3 | 292.1 | 238 | 255.3 | 271.4 | 320.6 | 236 | 256.9 | 290.5 | 346.7 | 265.9 | 283.7 |
| EBITDA 1 | 58.9 | 54 | 61.8 | 65.8 | 81.9 | 61.9 | 68.2 | 74.7 | 86.7 | 50.6 | 60.19 | 75.33 | 92.83 | 66.02 | 75.1 |
| EBIT 1 | 43.8 | 38.8 | 45.9 | 49.1 | 64.8 | 43.6 | 48.7 | 54.2 | 66.6 | 28.9 | 37.41 | 50.97 | 69.66 | 39.76 | 46.61 |
| Operating Margin | 18.83% | 18.29% | 19.6% | 20.02% | 22.18% | 18.32% | 19.08% | 19.97% | 20.77% | 12.25% | 14.56% | 17.55% | 20.09% | 14.95% | 16.43% |
| Earnings before Tax (EBT) 1 | 53.7 | 36.3 | 41.5 | 46 | 63.8 | 36 | 44.3 | 50.4 | 58.8 | 25.7 | 33.77 | 48.9 | 65.3 | 35.4 | 46.6 |
| Net income 1 | 44.6 | 27.8 | 30.6 | 36.3 | 48.3 | 28.3 | 34.3 | 37.9 | 45.2 | 18.8 | 25.95 | 36.48 | 51.36 | 26.38 | 32.67 |
| Net margin | 19.17% | 13.11% | 13.07% | 14.8% | 16.54% | 11.89% | 13.44% | 13.96% | 14.1% | 7.97% | 10.1% | 12.56% | 14.81% | 9.92% | 11.51% |
| EPS 2 | 0.1846 | 0.1053 | 0.1228 | 0.1400 | 0.1909 | 0.1210 | 0.1429 | 0.1485 | 0.1853 | 0.0754 | 0.1050 | 0.1460 | 0.2056 | 0.1050 | 0.1295 |
| Dividend per Share 2 | 0.0555 | - | - | - | - | - | - | - | - | - | - | 0.0700 | - | - | - |
| Announcement Date | 3/8/22 | 5/10/22 | 8/4/22 | 11/8/22 | 3/2/23 | 5/4/23 | 7/28/23 | 10/31/23 | 3/7/24 | 5/9/24 | - | - | - | - | - |
1EUR in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | 502 | 274 | 248 | 14.4 |
| Net Cash position 1 | - | 190 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | 1.724 x | 0.9844 x | 0.7428 x | 0.0368 x |
| Free Cash Flow 1 | - | 25.6 | -132 | -328 | -70.5 | 57.2 | 132 |
| ROE (net income / shareholders' equity) | - | 23.3% | - | 13.7% | 10.3% | 10.7% | 11.9% |
| ROA (Net income/ Total Assets) | - | 11.3% | - | 7.81% | 5.5% | 6.6% | 7.9% |
| Assets 1 | - | 1,193 | - | 1,866 | 2,395 | 2,503 | 2,545 |
| Book Value Per Share 2 | - | 3.640 | - | 4.670 | 5.680 | 6.250 | 6.950 |
| Cash Flow per Share 2 | - | 0.5700 | 0.4100 | 0.4300 | 1.120 | 1.130 | 1.410 |
| Capex 1 | - | 108 | 235 | 433 | 311 | 276 | 225 |
| Capex / Sales | - | 12.76% | 23.89% | 39.91% | 27.52% | 22.07% | 15.99% |
| Announcement Date | 4/30/21 | 3/8/22 | 3/2/23 | 3/7/24 | - | - | - |
1EUR in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
18.16
USD
Average target price
28.65
USD
Spread / Average Target
+57.78%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -31.75% | 4.95B | |
| -5.02% | 184B | |
| +0.32% | 107B | |
| -3.63% | 67.9B | |
| -5.88% | 46.49B | |
| +11.27% | 45.81B | |
| +6.38% | 42.55B | |
| +19.77% | 30.78B | |
| +16.53% | 26.11B | |
| -3.43% | 23.9B |
- Stock Market
- Equities
- STVN Stock
- Financials Stevanato Group S.p.A.
